Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.37 |
| ▸ | EPM2A | O95278 | 1/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1993262 | 0.91 | EPM2A (0.47) | RAB9AALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL258838 | 0.89 | GPR3 (0.61) | RAB9AALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL4915968 | 0.87 | ALOX15 (0.42) | RAB9AALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL4919520 | 0.87 | MIF (0.46) | RAB9AALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL18553236 | 0.87 | ALDH1A1 (0.42) | RAB9AALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL4921017 | 0.87 | ALDH1A1 (0.34) | RAB9AALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL4917236 | 0.87 | MAPT (0.62) | RAB9AALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL5019819 | 0.85 | HSP90AA1 (0.43) | RAB9AALDH1A1MAPTMIFCYP2A6 | |
| SCHEMBL30923497 | 0.85 | HSP90AA1 (0.43) | RAB9AALDH1A1MAPTMIFCYP2A6 | |
| SCHEMBL12925791 | 0.84 | HRH4 (0.40) | RAB9AALDH1A1MAPTMIFCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113061238-A | Red light polymer based on dibenzophenazine and preparation method thereof | 冯旗 | 2021-07-02 | — | — | CN | claimed |
| CN-104402929-A | Phosphine oxide derivative of dibenzothiophene S, S dioxides and preparation method and application thereof | UNIV HEILONGJIANG | 2015-03-11 | — | — | CN | claimed |
| US-20070099905-A1 | Combinations of drugs for the treatment of neoplasms | BORISY ALEXIS | 2007-05-03 | — | — | US | claimed |
| EP-1651211-A4 | COMBINATION OF DRUGS FOR THE TREATMENT OF NEOPLASMS | COMBINATORX INC (US) | 2006-11-22 | — | — | EP | claimed |
| CN-1829509-A | Pharmaceutical composition for treating tumors | COMBINATORX INC (US) | 2006-09-06 | — | — | CN | claimed |
| EP-1651211-A2 | COMBINATION OF DRUGS FOR THE TREATMENT OF NEOPLASMS | Combinatorx, Incorporated (US) | 2006-05-03 | — | — | EP | claimed |
| CN-1681511-A | Combinations of drugs for the treatment of neoplasms | COMBINATORX INC (US) | 2005-10-12 | — | — | CN | claimed |
| US-20050080075-A1 | Formulations, conjugates, and combinations of drugs for the treatment of neoplasms | COMBINATORX, INC. | 2005-04-14 | — | — | US | claimed |
| US-20050054708-A1 | Combinations of drugs for the treatment of neoplasms | COMINATORX, INCORPORATED | 2005-03-10 | — | — | US | claimed |
| WO-2005011572-A2 | COMBINATION OF DRUGS FOR THE TREATMENT OF NEOPLASMS | COMBINATORX, INCORPORATED (US) | 2005-02-10 | — | — | WO | claimed |
| US-20040116407-A1 | Combinations of drugs for the treatment of neoplasms | COMBINATORX, INC. | 2004-06-17 | — | — | US | claimed |
| WO-2004006849-A2 | COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS | COMBINATORX, INCORPORATED (US) | 2004-01-22 | — | — | WO | claimed |
| WO-2025063197-A1 | CRYSTAL, METHOD FOR PRODUCING CRYSTAL, AND METHOD FOR INDUCING SELF-ORGANIZATION OF SILANOL COMPOUND | 国立研究開発法人産業技術総合研究所 | 2025-03-27 | — | — | WO | disclosed |
| WO-2024253073-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2024-12-12 | — | — | WO | disclosed |
| US-20240279550-A1 | REACTIVE MESOGENS | MERCK PATENT GMBH (DE) | 2024-08-22 | — | — | US | disclosed |
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| EP-1105381-A1 | DICATIONIC DIBENZOFURAN AND DIBENZOTHIOPHENE COMPOUNDS AND METHODS OF USE THEREOF | The University of North Carolina at Chapel Hill (US) | 2001-06-13 | — | — | EP | disclosed |
| US-6172104-B1 | ADMINISTERING TO TREAT PNEUMOCYSTIS CARINII PNEUMONIA | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2001-01-09 | — | — | US | disclosed |
| WO-2000010990-A2 | DICATIONIC DIBENZOFURAN AND DIBENZOTHIOPHENE COMPOUNDS AND METHODS OF USE THEREOF | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2000-03-02 | — | — | WO | disclosed |
| US-4375427-A | DOPES, POLYTHIOETHERS | ALLIED CORPORATION (US) | 1983-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080075-A1 | Formulations, conjugates, and combinations of drugs for the treatment of neoplasms | ABCB1, SLCO1B3, SLCO1B1 | RAB9A 1496/4885ALDH1A1 571/4885MAPT 790/4885 |
| US-20070099905-A1 | Combinations of drugs for the treatment of neoplasms | VHL, NRAS, MYC | RAB9A 4125/4885ALDH1A1 662/4885MAPT 4349/4885 |
| US-20240279550-A1 | REACTIVE MESOGENS | MCHR1, MCHR2, OPRM1 | RAB9A 1267/4885ALDH1A1 2974/4885MAPT 1350/4885 |
| US-20050054708-A1 | Combinations of drugs for the treatment of neoplasms | TYMP, DPYD, DHFR | RAB9A 4034/4885ALDH1A1 1543/4885MAPT 4795/4885 |
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, AOC1 | RAB9A 2334/4885ALDH1A1 816/4885MAPT 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.